- Low
- 50,700
- Average
- 67,335
- Median
- 57,325
- High
- 110,968
American Oncologic Hospital Salary
12
27
62
| Job Title | Salaries | City | Year | More info |
| Senior Programmer Analyst | 72,405-72,405 | Indianapolis, IN, 46201 | 2013 | American Oncologic Hospital Senior Programmer Analyst Salaries (1) American Oncologic Hospital Indianapolis, IN Salaries |
| Software Quality Analyst | 62,504-62,504 | Indianapolis, IN, 46201 | 2013 | American Oncologic Hospital Software Quality Analyst Salaries (1) American Oncologic Hospital Indianapolis, IN Salaries |
Related American Oncologic Hospital Salary
- Analysis Group Salary
- Highdata Software Salary
- Infosys Bpo Limited Salary
- Marvel Technologies Salary
- Zenith Services Salary
- Spi Management Services Salary
- Sahasra Technologies Salary
- The University Of Texas M.d. Anderson Cancer Center Salary
- Datamatics Global Services Salary
- Jefferies Salary
- Atlas Systems Salary
- Thoughtwave Software And Solutions Salary
- Ecalix Salary
- Samsung Austin Semiconductor, Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
American Oncologic Hospital Jobs
| See more American Oncologic Hospital Jobs» | |
| Search All Jobs | |
Patents information
3
All Patents
0
Grant Patents
3
Patents Pending
2
Patents Families
More Recent
-
EP3325003A1COMBINATION OF IMMUNOMODULATORY AGENT WITH PD-1-OR PD-L1 CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER
-
AU2016297583A1Combination of immunomodulatory agent with PD-1-or PD-L1 checkpoint inhibitors in the treatment of cancer
-
CA2993179A1COMBINATION OF IMMUNOMODULATORY AGENT WITH PD-1-OR PD-L1 CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER
- View More »
Related American Oncolo... Information
